Gossamer Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
GOSS Nasdaq 8731 https://www.gossamerbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Gossamer Bio Inc

Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update - Mar 17th, 2023 11:31 am
Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success - Mar 7th, 2023 8:37 pm
15 Most Shorted Stocks Right Now on Wall Street - Mar 3rd, 2023 4:40 pm
7 Top Short-Squeeze Candidates to Watch in February - Feb 1st, 2023 9:25 pm
Gossamer Bio (GOSS) Upgraded to Buy: What Does It Mean for the Stock? - Jan 4th, 2023 5:00 pm
Gossamer Bio (GOSS) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Jan 4th, 2023 2:35 pm
Bullish insiders at Gossamer Bio, Inc. (NASDAQ:GOSS) loaded up on US$1.2m of stock earlier this year - Dec 26th, 2022 2:41 pm
Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis - Dec 6th, 2022 6:19 pm
Gossamer Bio Shares Plummet As Hypertension Trial Fall Short Of Expectation - Dec 6th, 2022 3:00 pm
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH - Dec 6th, 2022 12:15 pm
Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial - Nov 17th, 2022 7:37 pm
What Makes Gossamer Bio (GOSS) a New Buy Stock - Nov 8th, 2022 5:00 pm
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update - Nov 3rd, 2022 8:01 pm
Goldman Sachs Says These 2 Buy-Rated Stocks Have at Least 60% Upside Potential - Oct 24th, 2022 12:30 pm
With 62% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners - Aug 29th, 2022 12:11 pm
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update - Aug 9th, 2022 12:01 pm
2 ‘Strong Buy’ Stocks That ‘In-The-Know’ Bigwigs Are Pouring Money Into - Jul 21st, 2022 10:21 pm
Here's Why Gossamer Bio (GOSS) is a Great Momentum Stock to Buy - Jul 19th, 2022 4:00 pm
The Co-Founder of Gossamer Bio, Inc. (NASDAQ:GOSS), Faheem Hasnain, Just Bought 3.8% More Shares - Jul 19th, 2022 1:46 pm
Wall Street Analysts See a 52% Upside in Gossamer Bio (GOSS): Can the Stock Really Move This High? - Jul 18th, 2022 1:55 pm